Session Information
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: IL-6 plays an important role in the pathogenesis of large vessel vasculitis. Lipopolysaccharide (LPS), acting through toll-like receptor 4, enhances both the aortic expression as well as serum levels of IL-6. Previous work by our group has demonstrated that systemic mast cell degranulation will inhibit both the serum and aortic expression of IL-6 in LPS injected mice. Mast cells release many vasoactive substances including histamine, proteases, and IL-10 . Our hypothesis is that the inhibitory effect of mast cells on aortic IL-6 production is mediated through histamine and/or IL-10.
Methods: Two month-old male C57BI6 (WT) and Histamine 1 Receptor (H1R) -/- mice were randomized into four groups, and given intraperitoneal injections with normal saline (control), compound 48/80 (mast cell degranulation agent, 1mg/kg), LPS (1mg/kg) or C48/80+LPS. Mice were sacrificed 24-h later, and levels of the stable metabolites of prostaglandin I2 (PGI2) and thromboxane A2 (TXA2) in the urine, and IL-6 and IL-10 in sera were quantified.
Results: MC degranulation did not increase PGI2 in control or in LPS-treated mice of either genotype. LPS injection increased PGI2 in both genotypes, but the increase was higher in H1R-/- mice. Both C48/80 and LPS increased TXA2 in WT mice, but only LPS treatment enhanced TXA2 in H1R-/-mice indicating importance H1R in this pathway. Treatment with C48/80 did not further enhance prostanoid production over LPS. LPS treatment increased serum IL-6 in both genotypes, but the changes were significant only in WT mice. Interestingly, LPS-induced IL-6 production was significantly reduced by MC degranulation in WT mice, but not in H1R-/- mice. In WT mice the inhibition of IL-6 was associated with enhanced aortic expression of SOCS1. In comparison to WT, the basal and induced levels of IL-10 were markedly higher in H1R-/- mice.
Conclusion: Mast cells differentially regulate LPS-induced inflammatory response in WT and H1R -/- mice. These results suggest that MCs regulate LPS-induced systemic and aortic inflammatory response involving H1R, SOCS-1 and IL-10.
Acknowledgements: Supported by NIH grants R01-HL070101 & 3R01-HL070101-04S1, the Joseph & Elizabeth Carey Arthritis Fund and Audrey Smith Fund from KU Endowment Association, Lied Grant from KUMC Research Institute, and by the Department of Internal Medicine Research Office. H1R-null breeding pairs were graciously provided by Dr. Cory Teuscher, University of Vermont, Burlington, VT.
To cite this abstract in AMA style:
Raveendran V, Springer J, Smith D, Maz M, Dileepan K. Mast Cell Regulation of Aortic IL-6 Expression Involves Histamine-1 Receptor, Suppressor of Cyotkine Signaling-1 and IL-10 [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mast-cell-regulation-of-aortic-il-6-expression-involves-histamine-1-receptor-suppressor-of-cyotkine-signaling-1-and-il-10/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/mast-cell-regulation-of-aortic-il-6-expression-involves-histamine-1-receptor-suppressor-of-cyotkine-signaling-1-and-il-10/